Table 2 Preoperative medication in three group
Group S (n = 20) | Group L (n = 20) | Group H (n = 20) | P value | |
|---|---|---|---|---|
Chronic beta-blockaden n (%) | 3 (15%) | 2 (10) | 1 (5%) | 0.625 |
ACE inhibitorsn n (%) | 1 (5%) | 1 (5) | 2 (10%) | |
calcium antagonistsn n (%) | 0 | 1 (5%) | 3 (15%) |
Group S (n = 20) | Group L (n = 20) | Group H (n = 20) | P value | |
|---|---|---|---|---|
Chronic beta-blockaden n (%) | 3 (15%) | 2 (10) | 1 (5%) | 0.625 |
ACE inhibitorsn n (%) | 1 (5%) | 1 (5) | 2 (10%) | |
calcium antagonistsn n (%) | 0 | 1 (5%) | 3 (15%) |